Evidence map›Paper›PMID 41595200›Full record

ArticleCancers2026

Aberrant CD25 and Increased CD123 Expression Are Common in Acute Myeloid Leukemia with

Qing Wei, Guilin Tang, Shaoying Li, Sa A Wang, Pei Lin, Wei Wang, Sanam Loghavi, Wei J Wang, L Jeffrey Medeiros, Jie Xu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qing WeiDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.ORCID 0000-0003-0141-9682
Guilin TangDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.ORCID 0000-0002-9482-4806
Shaoying LiDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
Sa A WangDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
Pei LinDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
Wei WangDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
Sanam LoghaviDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.ORCID 0000-0001-8980-3202
Wei J WangDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.
L Jeffrey MedeirosDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.ORCID 0000-0001-6577-8006
Jie XuDepartment of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, TX 77030, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsWe identified 47 cases of AML with

resultsThe cohort included 32 men and 15 women with a median age of 67 years (range, 19-87). Thirty-eight cases were de novo AML, and nine were secondary to myelodysplastic syndrome and/or myeloproliferative neoplasm. Most cases (93%) demonstrated a normal or non-complex karyotype. The most frequent mutations involved

conclusionsAML with

Indexed as

AMLCD123CD25FLT3 ITDimmunophenotypeKMT2A PTD

Identifiers

PMID41595200
PMCPMC12839231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.